Exact Sciences’ Cologuard Gets Panel Nod As Colorectal Cancer Screen
This article was originally published in The Pink Sheet Daily
Executive Summary
Exact Sciences Corp.’s Cologuard stool test for colorectal cancer screening gained full support from the FDA Molecular and Clinical Genetics Advisory Panel March 27, putting it in a good position to gain approval and, potentially, a Medicare national coverage determination.